Not Signed In - Innovative Trial Design Could Reduce Time To Market
Sat, 17 Feb 2007 01:00 AM EST
... Destination Therapy (DT) TrialThe DT Protocol is a prospective, randomized, controlled trial with two modules. Both modules have event driven end points.Module A (primary) consists of 180 patients with 2:1 randomization of the VentrAssist to the control arm, which does not require implantation of an LVAD approved by the FDA for DT. [click link for full article] ...
Related Topics
- Clinical Trials
- Research
- Piercing and Tattoos
- Cerivastatin - Withdrawn From The Market
- more...
- Wrinkles
- Tragacanth
- Rofecoxib Oral Suspension
- Basics
- Small Businesses
- Alprostadil pellets
- LH
- Crisis
- Stroke, if clots break off and travel to the brain (drugs that thin the blood such as heparin and warfarin can reduce the risk)
- Too many steroid injections over a short period of time can cause injury to the surrounding tendons.
- Travelers' Health
- Flunisolide Nasal Inhalation
- Desipramine
- Trastuzumab
- CVD
email this page
print this page
bookmark this page
feedback on this page
